title: The brain tumor board: lessons to be learned from an interdisciplinary conference.
abstract: BACKGROUND
  The aim of this study is to analyze the work of the interdisciplinary Brain Tumor Board (BTB) which was established at Freiburg University Hospital in 1998.
  
  
  METHODS
  From January 1998 to December 2003, a total of 1,516 patients were discussed in 259 meetings of the BTB. The protocols of the BTB were analyzed retrospectively.
  
  
  RESULTS
  In 79% of the patients, the diagnosis was based on histological findings or a typical radiological appearance of a lesion, or both. This group was composed of 4 subgroups: 28% benign skull base tumors (19% meningiomas, 4% pituitary adenomas, 3% acoustic schwannomas, 2% others), 24% primary brain tumors of glial origin (8% glioblastomas, 12% gliomas other than glioblastomas, 5% oligoastrocytomas or oligodendrogliomas), 19% brain metastases, and 8% other brain or skull base tumors. In 13% of the cases, the exact diagnosis was still unknown when the patient was presented. 8% of the presentations were motivated by nontumorous interdisciplinary problems (e.g. arterio-venous malformations). The recommendations given by the BTB included: 23% further diagnostic procedures (11% non-invasive examinations, 12% stereotactic biopsies), 57% active antitumoral therapy (22% resection, 17% fractionated radiotherapy, 13% radiosurgery, 5% chemotherapy, <1% embolization), 20% no treatment (14% watchful waiting, 6% supportive care). 91% of the BTB recommendations were realized within 3 months.
  
  
  CONCLUSIONS
  Interdisciplinary care seems to be particularly necessary in patients with benign skull base tumors, gliomas and brain metastases. Decisions made in a small interdisciplinary group of experts have a high potential of subsequently being realized.
authors.affiliation: Department of Radiation Oncology, University Hospital, Freiburg, Germany. lutterba@mst1.ukl.uni-freiburg.de
authors.forename: Johannes
authors.initials: J
authors.lastname: Lutterbach
authors.forename: Axel
authors.initials: A
authors.lastname: Pagenstecher
authors.forename: Joachim
authors.initials: J
authors.lastname: Spreer
authors.forename: Andreas
authors.initials: A
authors.lastname: Hetzel
authors.forename: Vera van
authors.initials: Vv
authors.lastname: Velthoven
authors.forename: Guido
authors.initials: G
authors.lastname: Nikkhah
authors.forename: Hermann
authors.initials: H
authors.lastname: Frommhold
authors.forename: Benedikt
authors.initials: B
authors.lastname: Volk
authors.forename: Martin
authors.initials: M
authors.lastname: Schumacher
authors.forename: Carl
authors.initials: C
authors.lastname: Lücking
authors.forename: Josef
authors.initials: J
authors.lastname: Zentner
authors.forename: Christoph
authors.initials: C
authors.lastname: Ostertag
mesh_terms: D000046:Academic Medical Centers / Q000706:statistics & numerical data; D000293:Adolescent; D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D026661:Clinical Trials Data Monitoring Committees / Q000706:statistics & numerical data*; D020000:Decision Support Systems, Clinical / Q000706:statistics & numerical data*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010348:Patient Care Team / Q000706:statistics & numerical data*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D011785:Quality Assurance, Health Care / Q000706:statistics & numerical data*; D012189:Retrospective Studies